There is no doubt that Companhia Brasileira De Distribuicao (CBD) ticks all the boxes.

Companhia Brasileira De Distribuicao (NYSE: CBD) stock fell -6.01% on Friday to $0.86 against a previous-day closing price of $0.91. With 0.84 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.66 million shares. During the session, the Department Stores company that operates in wider Consumer Cyclical sector, reached to the highest price of $0.8801 whereas the lowest price it dropped to was $0.8500. The 52-week range on CBD shows that it touched its highest point at $1.49 and its lowest point at $0.79 during that stretch. It currently has a 1-year price target of $3.10. With its current market cap of 254.26 million, CBD has annualized dividend of $0.07 while the current yield stands at 8.07%. Beta for the stock currently stands at 1.38.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of CBD was down-trending over the past week, with a drop of -0.56%, but this was down by -29.29% over a month. Three-month performance dropped to -26.04% while six-month performance rose 0.98%. The stock lost -33.09% in the past year, while it has lost -11.72% so far this year. A look at the trailing 12-month EPS for CBD yields -1.03 with Next year EPS estimates of -2.11.

Float and Shares Shorts:

At present, 270.00 million CBD shares are outstanding with a float of 158.93 million shares on hand for trading. On Aug 30, 2023, short shares totaled 3.9 million, which was 1.45% higher than short shares on Jul 30, 2023. In addition to Mr. Marcelo Ribeiro Pimentel as the firm’s CEO & Director, Mr. Rafael Sirotsky Russowsky serves as its CFO and VP of Fin. & Investor Relations.

Institutional Ownership:

Through their ownership of 5.30% of CBD’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 3.71% of CBD, in contrast to 1.15% held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in CBD with 0.87% of the stake, Carronade Capital Management LP holds 2,340,000 shares worth 2,340,000. A second-largest stockholder of CBD, Banco BTG Pactual SA, holds 1,840,093 shares, controlling over 0.68% of the firm’s shares. Merrill Lynch International is the third largest shareholder in CBD, holding 1,045,039 shares or 0.39% stake. With a 0.19% stake in CBD, the Avantis Emerging Markets Equity E is the largest stakeholder. A total of 503,087 shares are owned by the mutual fund manager. The Vanguard Total International Stoc, which owns about 0.17% of CBD stock, is the second-largest Mutual Fund holder. It holds 455,545 shares valued at 1.8 million. SPDR Portfolio Emerging Markets E holds 0.14% of the stake in CBD, owning 384,827 shares worth 1.52 million.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, CBD reported revenue of $10.12B and operating income of $279.00M. The EBITDA in the recently reported quarter was $692.00M and diluted EPS was -$0.64.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for CBD since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With CBD analysts setting a high price target of $6.02 and a low target of $2.66, the average target price over the next 12 months is $4.05. Based on these targets, CBD could surge 600.0% to reach the target high and rise by 209.3% to reach the target low. Reaching the average price target will result in a growth of 370.93% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Leave a Comment

Your email address will not be published. Required fields are marked *